Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
about
Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.Optimizing management of distal ulcerative colitis.Use of antibiotics in the treatment of inflammatory bowel disease.Crohn's disease and the mycobacterioses: a quarter century later. Causation or simple association?Kefir treatment ameliorates dextran sulfate sodium-induced colitis in rats.
P2860
Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
@ast
Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
@en
Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
@nl
type
label
Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
@ast
Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
@en
Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
@nl
prefLabel
Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
@ast
Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
@en
Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
@nl
P2860
P1476
Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
@en
P2093
Nobuhiro Sato
Toshifumi Ohkusa
P2860
P304
P356
10.1111/J.1440-1746.2004.03472.X
P577
2005-03-01T00:00:00Z